Resource Center

< Back to Member Portal Home

Resource Center

This resource center is a place for you to learn more and get the tools you need to be successful, so explore! And, of course, always feel free to join the conversation.

Nutrition Resources

Guidance for what to eat to make your journey a successful one and great recipes to make it a delicious one.

Physical Activities

Ideas to find new activities to enjoy and how to incorporate movement into your day.

Metabolic Health

Information on the latest research around metabolic health and what it means for you.

Medication Information

Information on different anti-obesity medications – what they are, how they work, and what to expect from using them.

Bariatric Procedures

Information on different bariatric procedures – what they are, how they work, and what to expect before, during, and after.

Join the Conversation

Our community chats for whatever might be on your mind.

News

Latest Research & Reports

A collection of the latest news about obesity and metabolic health.

Ilant Health and Galway Holdings Partner to Offer Obesity and Cardiometabolic Health Center of Excellence to Employees and Employer Clients

Galway Holdings, a prominent financial services firm, will provide Ilant’s industry-leading Obesity and Cardiometabolic Center of Excellence to Galway’s employees.

November 12, 2024

Anti-Obesity Medication

Employees are asking about GLP-1 coverage. What should employers do?

Our Founder and CEO, Elina Onitskansky, highlights the importance of capturing value from obesity treatment, the rising costs of obesity-related conditions like diabetes and cardiovascular disease, and how it's essential to find financially sustainable approaches.

October 24, 2024

As Interest in GLP-1 Drugs Spikes, Employers Weigh the Costs, Benefits

CEO Elina Onitskansky, shares insights as to why a "GLPs-for-all" strategy isn't the answer, discusses the importance of moving beyond this mentality and focusing on personalized care that leverages data, analytics, and evidence-based approaches to drive better outcomes.

October 8, 2024

Anti-Obesity Medication

First Medicare Health Plans to Start Paying for Weight-Loss Drug Wegovy

Programs run by Elevance, Kaiser Permanente and CVS Health have decided to extend coverage of the medicine for people with heart-related conditions

The Wall Street Journal

Physical Activity

The Race Is On to Stop Ozempic Muscle Loss

Gym chains, nutrition startups and drugmakers all want to solve a common issue among people who take weight loss drugs.

The New York Times

February 8, 2024

Anti-Obesity Medication

Many Patients Maintain Weight Loss a Year After Stopping Semaglutide and Liraglutide

Study finds two-thirds of patients are able to maintain weight loss achieved while on semaglutide or liraglutide even a year after discontinuing the medication.

January 23, 2024

Bariatric Procedures

The Ozempic effect: Insurers ease access to bariatric surgery

Health insurance companies are expanding their coverage of bariatric surgery amid rising demand for expensive new weight loss drugs.

Modern Healthcare

January 4, 2024

Anti-Obesity Medication

Comparative Effectiveness of Semaglutide and Tirzepatide for Weight Loss

Both tirzepatide and semaglutide have been shown to reduce weight for patients with overweight or obesity in randomized controlled trials (RCTs). While tirzepatide appears to provide greater weight loss than semaglutide in this population, head-to-head RCTs are not yet available.

November 22, 2023

Value-based obesity treatment provider Ilant Health launches out of stealth

“We only do well when our customers do well.” Thank you Fierce Healthcare for the coverage of Ilant’s launch. Our solution is designed to serve commercial, Medicaid and Medicare populations, enabled by value-based payments to help align financial incentives with outcomes.

Fierce Healthcare

October 20, 2023

Ilant Health seeds $3M for VBC obesity treatment

Axios team, thank you for covering Ilant's public launch - we're excited to share our holistic approach to obesity care and to support employers and payors in managing quality and cost of obesity care for members.

October 17, 2023

Anti-Obesity Medication

Here’s what it would take for insurance to cover weight loss drugs

"HR benefits specialists really see a potential role as far as improving and treating obesity and its other related conditions and improving quality of life for employees. But now we're really looking at and are hoping for more information on that financial side." – Dr. Gudzune

October 16, 2023

Anti-Obesity Medication

U.S. employers covering weight-loss drugs could nearly double in 2024 - survey

We’re seeing real divergence in expectations for AOMs. While Reuters estimates employers covering AOMs will double in 2024, we’re seeing large employers (Hennepin, Ascension, UoT) dropping coverage. Why the discrepancy? Employers want both effective and affordable care.

October 10, 2023

Anti-Obesity Medication

How Ozempic and Wegovy Could Break the Healthcare System

Between cost and demand, the latest breed of weight-loss drugs could transform healthcare in the U.S.— for good and ill.

September 21, 2023

Anti-Obesity Medication

GLP-1s give us a path to beating obesity, but making it a reality won’t be easy.

Decades of efforts to control obesity through exercise, dieting, surgery and drugs have proven an unmitigated failure. While these options may work for some patients, none of these interventions—either alone or in combination—have produced sustained, population-level results.

September 7, 2023

Bariatric Procedures

What do new weight loss drugs mean for the future of bariatric surgery?

Over the past year, weight loss drugs have captured the public’s imagination but also raised existential questions about the future of bariatric surgery.

September 6, 2023

Anti-Obesity Medication

Obesity specialists are scarce. Here’s how that’s starting to change.

Treatment of obesity has never been more prominent, with the advent of medications like Ozempic and Mounjaro generating both excitement and concern. Overlooked, however, is a severe shortage of doctors who actually specialize in treating obesity.

August 31, 2023

Metabolic Health

Brain’s "appetite control center" different in people who are overweight or living with obesity

The hypothalamus, a small region in the brain that controls hunger and feeling full, was significantly larger in young adults who had obesity or were overweight in a new study published in the journal Neuroimage: Clinical.

Medical News Today

Anti-Obesity Medication

Obesity drug Wegovy’s landmark trial result could ‘open up’ health insurance access, analyst says.

Popular weight-loss drug Wegovy could be made available under more health insurance schemes following the results of a late-stage trial, analysts said.

Anti-Obesity Medication

Weight Loss Drug Cuts Risk of Heart Problems, Maker Says

A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial.

The New York Times

Anti-Obesity Medication

Insurance Providers Are Halting Coverage of Ozempic and Other GLP-1 Drugs

The popularity of Ozempic, Wegovy, and other GLP-1 drugs has skyrocketed recently due to their ability to help people lose weight. However, some insurance companies and employers are halting coverage of these medications due to increasing costs.

Anti-Obesity Medication

Semaglutide Use May Lead to Muscle Loss Without Resistance Training, Doctors Advise Balancing Fat and Muscle.

People who take weight loss drugs such as semaglutide must do resistance training to prevent muscle loss, doctors have warned.

February 1, 2023

Anti-Obesity Medication

The Next Generation Of Weight-Loss Drugs Will Be Even More Powerful Than Ozempic

An obesity doctor explains what most people are getting wrong about these medications.

January 31, 2023

Metabolic Health

Obesity and belly bulge linked to being 'frail' later in life: study

Researchers in Norway recently released a prospective cohort study that looked into the relation body mass indexes (BMI) and waist circumferences (WC) have on "pre-frailty" and "frailty" in older adults, and they published their findings in BMJ Open, a peer-reviewed open access m

January 24, 2023

Metabolic Health

U.S. experts recommend weight-loss drugs for obese children

The American Academy of Pediatrics (AAP) on Monday recommended use of weight-loss drugs in children ages 12 years or older for treatment of obesity, which impacts about 14.4 million kids and adolescents in the United States and can lead to serious health complications.

January 9, 2023

Metabolic Health

Recognizing and Treating Obesity as a Disease

Almost half of American adults have obesity, a condition that was a fraction of that just 40 years ago and scientists don't agree on what's caused the dramatic increase. What everyone does agree on is that it's a major health crisis, because obesity can cause type 2 diabetes...

January 1, 2023

Anti-Obesity Medication

A new weight loss drug could become the best-selling drug of all time. Who can afford it?

An Eli Lilly drug if approved for weight loss could become the best-selling drug of all time, but concerns are mounting about who will actually be able to afford it. Experts are confident that the drug, called tirzepatide, will be granted approval by the FDA...

January 1, 2023

Bariatric Procedures

New research shows unexpected health benefits of bariatric surgery

Gastric bypass and other weight loss procedures, collectively known as “bariatric surgery,” are used by some obese people to shed extra pounds. Worldwide, around 580,000 people undergo these procedures each year. But bariatric surgery offers benefits beyond weight loss.

December 20, 2022

Bariatric Procedures

New guidelines expand eligibility for weight loss surgery. Will insurance coverage follow?

Weight loss surgery has become dramatically safer in recent decades and shown to reverse or improve dozens of weight-related diseases, but guidelines last set in 1991 haven't been updated to reflect the improvements. That's why the American Society for Metabolic...

October 21, 2022